Skip to content
2000
Volume 11, Issue 1
  • ISSN: 2212-697X
  • E-ISSN: 2212-6988

Abstract

Introduction

Bibliometrics quantitatively analyzes academic publications to evaluate trends, key studies, and scholarly impact, while patentometrics analyzes patent data to monitor innovation and commercialization. This systematic review focuses on Glutathione Peroxidase X4 (GPX4), a key regulator of oxidative stress and ferroptosis, to identify trends and innovations in cancer therapy.

Methods

Various research articles, reviews, and patents related to GPX4 and cancer were retrieved using databases such as Scopus, Google Scholar and WIPO PatentScope. Data analysis and visualization were performed with VOS Viewer. All documents available in the English language are included in the study. To minimize bias, two reviewers independently screened records, resolving conflicts through discussion or with a third reviewer.

Results

Using the Scopus, Google Scholar database and WIPO PatentScope, 587 research publications (research articles & reviews) and 1083 patents related to GPX4 and cancer were retrieved. The study showed rapid growth in research output, with high-impact research frequently published in the Journal of Cell. China contributed the most research articles, while the USA led in patent filings. Tang, D. was the most prolific author, and Marcus Conrad received the highest number of citations. Patent filings surged notably through 2024, with Remix Therapeutics submitting the most applications, underscoring the growing commercial interest in GPX4-targeted cancer therapies.

Discussion

The upward trends in publications and patents reflect increasing scientific and translational focus on GPX4. While the study highlights emerging leaders and innovations, limitations include exclusion of non-English literature and reliance on Scopus and Google Scholar, which may miss relevant works. Citations may also undervalue recent research.

Conclusion

This analysis provides insights into research hotspots, influential contributors, and emerging patterns in GPX4-related cancer research. It underscores the promising scope of GPX4-based interventions, fostering innovative approaches to the revolutionize cancer treatment. Researchers and innovators can leverage these findings to accelerate advancements in this critical domain.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccand/10.2174/012212697X379457250917235622
2025-09-24
2026-03-06

  • From This Site

    /content/journals/ccand/10.2174/012212697X379457250917235622
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Cancer today2024Available from: https://gco.iarc.fr/en
  2. MahaseE. Cancer overtakes CVD to become leading cause of death in high income countries.BMJ2019366l536810.1136/bmj.l5368 31481521
     [Google Scholar]
  3. WeiY. LvH. ShaikhA.B. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.Biochim. Biophys. Acta, Gen. Subj.20201864412953910.1016/j.bbagen.2020.129539 31958545
     [Google Scholar]
  4. LeeJ. RohJ.L. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.Cancer Lett.202355921611910.1016/j.canlet.2023.216119 36893895
     [Google Scholar]
  5. YangWS SriRamaratnam R WelschME Regulation of ferroptotic cancer cell death by GPX4.Cell20141561-231733110.1016/j.cell.2013.12.010 24439385
     [Google Scholar]
  6. ZhouQ. MengY. LiD. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.Signal Transduct. Target. Ther.2024915510.1038/s41392‑024‑01769‑5 38453898
     [Google Scholar]
  7. LiuY. LuS. WuL. YangL. YangL. WangJ. The diversified role of mitochondria in ferroptosis in cancer.Cell Death Dis.202314851910.1038/s41419‑023‑06045‑y 37580393
     [Google Scholar]
  8. Veglia TrancheseR. BattistaS. CerchiaL. FedeleM. Ferroptosis in cancer: Epigenetic control and therapeutic opportunities.Biomolecules20241411144310.3390/biom14111443 39595619
     [Google Scholar]
  9. DiaoJ. JiaY. DaiE. Ferroptotic therapy in cancer: Benefits, side effects, and risks.Mol. Cancer20242318910.1186/s12943‑024‑01999‑9 38702722
     [Google Scholar]
  10. WeiC. The role of glutathione peroxidase 4 in neuronal ferroptosis and its therapeutic potential in ischemic and hemorrhagic stroke.Brain Res. Bull.202421711106510.1016/j.brainresbull.2024.111065 39243947
     [Google Scholar]
  11. DongY. XuC. GuoJ. LiuY. Advances in ferroptosis of cancer therapy.Oncologie20242611810.1515/oncologie‑2023‑0513
     [Google Scholar]
  12. ZhangW. LiuY. LiaoY. ZhuC. ZouZ. GPX4, ferroptosis, and diseases.Biomed. Pharmacother.202417411651210.1016/j.biopha.2024.116512 38574617
     [Google Scholar]
  13. LiuJ. TangD. KangR. Targeting GPX4 in ferroptosis and cancer: Chemical strategies and challenges.Trends Pharmacol. Sci.202445866667010.1016/j.tips.2024.05.006 38866667
     [Google Scholar]
  14. ZhaoM. XuJ. ZhuS. LiP. Unraveling the role of GPX4 pathway in ferroptosis and its implications for gastric cancer management.J. Biomed. Res. Environ. Sci.20234121692169610.37871/jbres1854
     [Google Scholar]
  15. SekharK.R. HannaD.N. CyrS. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.Sci. Rep.20221211939610.1038/s41598‑022‑23906‑2 36371529
     [Google Scholar]
  16. KimJ.W. MinD.W. KimD. GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis.Sci. Rep.2023131887210.1038/s41598‑023‑35978‑9 37258589
     [Google Scholar]
  17. MaL. ShaoW. ZhuW. Exploring the molecular mechanisms and potential therapeutic strategies of ferroptosis in ovarian cancer.Biocell202448337938610.32604/biocell.2024.047812
     [Google Scholar]
  18. LiL. QiuC. HouM. Ferroptosis in ovarian cancer: A novel therapeutic strategy.Front. Oncol.20211166594510.3389/fonc.2021.665945 33996593
     [Google Scholar]
  19. BattagliaA.M. SaccoA. PerrottaI.D. Iron administration overcomes resistance to erastin-mediated ferroptosis in ovarian cancer cells.Front. Oncol.20221286835110.3389/fonc.2022.868351 35433479
     [Google Scholar]
  20. TangZ. LiJ. PengL. Novel covalent probe selectively targeting glutathione peroxidase 4 in vivo: Potential applications in pancreatic cancer therapy.J. Med. Chem.20246731872188710.1021/acs.jmedchem.3c01608 38265413
     [Google Scholar]
  21. MaS. HensonE.S. ChenY. GibsonS.B. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.Cell Death Dis.201677230710.1038/cddis.2016.208 27441659
     [Google Scholar]
  22. MengG. XuH. YangS. Bibliometric analysis of worldwide research trends on breast cancer about inflammation.Front. Oncol.202313116669010.3389/fonc.2023.1166690 37152044
     [Google Scholar]
  23. ZhengF. WangL. ZengZ. WuS. International technologies on prevention and treatment of neurological and psychiatric diseases: Bibliometric analysis of patents.JMIR Ment. Health2022922523810.2196/25238 35191849
     [Google Scholar]
  24. XinY. ManW. YiZ. The development trend of artificial intelligence in medical: A patentometric analysis.Artif. Intell. Life Sci.2021110000610.1016/j.ailsci.2021.100006
     [Google Scholar]
  25. ZhouH. MaoY. ZhouZ. Charting the course of ferroptosis research in lung cancer: Insights from a bibliometric analysis.Heliyon20241022481010.1016/j.heliyon.2024.e24810 38312575
     [Google Scholar]
  26. ZhangR. JiangQ. ZhuangZ. ZengH. LiY. A bibliometric analysis of drug resistance in immunotherapy for breast cancer: Trends, themes, and research focus.Front. Immunol.202415145230310.3389/fimmu.2024.1452303 39188717
     [Google Scholar]
  27. ZhangJ. LuoZ. ZhengY. A bibliometric study and visualization analysis of ferroptosis-inducing cancer therapy.Heliyon2023991980110.1016/j.heliyon.2023.e19801 37809417
     [Google Scholar]
  28. DengH. WeiJ. MinK. Research trends in ferroptosis since the origin of the concept: A bibliometric analysis.Clin. Exp. Pharmacol. Physiol.202350214915710.1111/1440‑1681.13732 36301241
     [Google Scholar]
  29. PageM.J. McKenzieJ.E. BossuytP.M. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.BMJ202137271n7110.1136/bmj.n71 33782057
     [Google Scholar]
  30. van EckN.J. WaltmanL. Software survey: VOSviewer, a computer program for bibliometric mapping.Scientometrics201084252353810.1007/s11192‑009‑0146‑3 20585380
     [Google Scholar]
  31. van EckN.J. WaltmanL. DekkerR. van den BergJ. A comparison of two techniques for bibliometric mapping: Multidimensional scaling and VOS.J. Am. Soc. Inf. Sci. Technol.201061122405241610.1002/asi.21421
     [Google Scholar]
  32. KhanM.S. Al-MaimaniA. Mapping research trends on renewable energy using VOSviewer: A bibliometric analysis.Energy Rep.202282762277310.1016/j.egyr.2022.01.186
     [Google Scholar]
  33. ZupicI. ČaterT. Bibliometric methods in management and organization.Organ. Res. Methods201518342947210.1177/1094428114562629
     [Google Scholar]
  34. SweilehW.M. Bibliometric analysis of peer-reviewed literature on health-related SDGs using Scopus database.Global. Health202016111210.1186/s12992‑020‑00651‑7 31898532
     [Google Scholar]
  35. DonthuN. KumarS. MukherjeeD. PandeyN. LimW.M. How to conduct a bibliometric analysis: An overview and guidelines.J. Bus. Res.202113328529610.1016/j.jbusres.2021.04.070
     [Google Scholar]
  36. XieY. HouW. SongX. Ferroptosis: Process and function.Cell Death Differ.201623336937910.1038/cdd.2015.158 26794443
     [Google Scholar]
  37. DollS. PronethB. TyurinaY.Y. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.Nat. Chem. Biol.2017131919810.1038/nchembio.2239 27842070
     [Google Scholar]
  38. GaoM. YiJ. ZhuJ. Role of mitochondria in ferroptosis.Mol. Cell2019732354363.e310.1016/j.molcel.2018.10.042 30581146
     [Google Scholar]
  39. CaoJ.Y. DixonS.J. A peroxidation mechanism drives ferroptosis.Nat. Chem. Biol.2016121687410.1038/nchembio.1969
     [Google Scholar]
  40. SeibtT.M. PronethB. ConradM. Ferroptosis: Biology and importance.Nat. Rev. Mol. Cell Biol.201920528229610.1038/s41580‑018‑0142‑6
     [Google Scholar]
  41. LeiG. ZhuangL. GanB. The role of NRF2 in ferroptosis.Nat. Commun.20201114410.1038/s41467‑019‑14029‑2
     [Google Scholar]
  42. ChuB. KonN. ChenD. GPX4: Mechanisms and function.Nat. Chem. Biol.201915767768610.1038/s41589‑019‑0301‑6
     [Google Scholar]
  43. ZouY. HenryW.S. RicqE.L. CDGSH iron sulfur domain 1 inhibits ferroptosis.Nat. Chem. Biol.201915772172910.1038/s41589‑019‑0304‑3 31209347
     [Google Scholar]
  44. YuH. GuoP. XieX. WangY. ChenG. XuY. Ferroptosis as a therapeutic strategy.Cancer Res.201777216124613210.1158/0008‑5472.CAN‑17‑0869 28923857
     [Google Scholar]
  45. MaiorinoM. ConradM. UrsiniF. GPX4 in lipid peroxidation and cell death.Antioxid. Redox Signal.2018291617410.1089/ars.2017.7115 28462584
     [Google Scholar]
  46. DixonS.J. LembergK.M. LamprechtM.R. Ferroptosis: An iron-dependent form of nonapoptotic cell death.Cell201214951060107210.1016/j.cell.2012.03.042 22632970
     [Google Scholar]
  47. HassanniaB. VandenabeeleP. Vanden BergheT. Targeting ferroptosis to iron out cancer.Cancer Cell201935683084910.1016/j.ccell.2019.04.002 31105042
     [Google Scholar]
/content/journals/ccand/10.2174/012212697X379457250917235622
Loading
A Systematic Review: Bibliometric and Patentometric Insights into Glutathione Peroxidase 4 Innovations in Cancer Treatment
Clinical Cancer Drugs 11, E2212697X379457 (2025); https://doi.org/10.2174/012212697X379457250917235622
/content/journals/ccand/10.2174/012212697X379457250917235622
/content/journals/ccand/10.2174/012212697X379457250917235622
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): Bibliometric; cancer therapy; cardiovascular disease; ferroptosis; GPX4; patentometric

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test